Skip to content
healthcare.dev

ZERBAXA

NDC 67919-030, ceftolozane and tazobactam, injection, powder, lyophilized, for solution, from Merck Sharp & Dohme LLC.

Product NDC
67919-030
Status
Listed
Labeler
Merck Sharp & Dohme LLC
Dosage form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA206829
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67919-030 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CEFTOLOZANE SULFATE1 g/10mL
  • TAZOBACTAM SODIUM.5 g/10mL

Pharmacologic classes

Cephalosporin Antibacterial [EPC]; Cephalosporins [CS]; beta Lactamase Inhibitor [EPC]; beta Lactamase Inhibitors [MoA]

Package NDCNDC-11Package
67919-030-016791900300110 VIAL, SINGLE-DOSE in 1 CARTON (67919-030-01) / 10 mL in 1 VIAL, SINGLE-DOSE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/70ac1d90-eff3-4f0b-9f46-5846c571b32f
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=67919-030

Use it

Look up 67919-030 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67919-030 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67919-030. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.